v3.25.3
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Nov. 30, 2014
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 252,169 234,026 239,040 234,026  
Limited partner units (in shares) 405,998   405,998   405,908
Class B units (in shares) 359,250 359,250 359,250 359,250  
Advisor | American Realty Capital Healthcare III Advisors, LLC          
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Limited partner units (in shares) 405,998 405,998 405,998 405,998  
Unvested Restricted Stock          
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Unvested restricted stock (in shares) 200,422 0 200,422 0  
Unvested Restricted Stock          
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 18,143 0 5,014 0  
Common OP Units          
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 124,161 124,161 124,161 124,161  
Class B Units          
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 109,865 109,865 109,865 109,865